Entering text into the input field will update the search result below
Create free account
Search for Symbols, analysts, keywords
Log in
News
Trending News
AI Tech
All News
Biotech
Buybacks
Commodities
Consumer
Cryptocurrency
Debt/Share Issuance
Dividends - Funds
Dividends - Stocks
Earnings
Energy
Financials
Global Macro
Graphical News
Guidance
Healthcare
Interest Rates
IPOs
M&A
Magnificent 7
Market Pulse
MLPs
Notable Calls
On The Move
Politics
REITs
SPACs
Tech
Top News
U.S Economy
Weight Loss
Show Full Stories
Sanofi to invest over €1 billion in French production sites
8 out of 12 S&P 500 healthcare companies beat profit consensus this week: Earnings Scorecard
Cantor picks 14 undervalued biotech stocks worth a second look
JPMorgan: Defensive sectors, like health care and utilities, could outperform
Exelixis files patent suit against India’s Cipla over Cabometyx generics
Cannabis rescheduling unlikely to happen by end of year -- Seeking Alpha survey
U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact
U.S. pledges nearly $200M to prevent bird flu spread on dairy farms
Novavax’s sudden rise burns short sellers: report
Tevogen Bio secures up to $50M in financing
Bristol Myers' Opdivo fails in Phase 3 lung cancer study
Merrimack Pharmaceuticals stockholders approve plan of dissolution
Cassava swings to Q1 profit as more patients finish simufilam phase 3 trials
Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (update)
Marijuana THC potency at all-time high - DEA
ADMA Biologics hits 52-week high on Q1 beat, guidance raise
AI-discovered drugs have an 80%–90% success rate: study
CareDx rises as much as 38%, highest intraday gain in six years
Collegium downgraded by Piper Sandler over valuation
Lilly could partner with Cipla to market GLP-1 drugs in India - report
Novavax hits 52-week high as Sanofi deal brings upgrades (update)
Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires
Baxter downgraded to hold by TD Cowen in wake of selloff
U.S. to issue new tariffs against Chinese-made medical supplies: Reuters
Evolent down 9% despite quarterly beats on Q2 EBITDA guidance
1
2
3
4
5
Next
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.